The Efficacy of Andrographis paniculata and Chromolaena odorata Plant Extract against Malaria Parasite

Malaria constitutes one of the major health problems
in Nigeria. One of the reasons attributed for the upsurge was the
development of resistance of Plasmodium falciparum and the
emergence of multi-resistant strains of the parasite to anti-malaria
drugs. A continued search for other effective, safe and cheap plantbased
anti-malaria agents thus becomes imperative in the face of
these difficulties. The objective of this study is therefore to evaluate
the in vivo anti-malarial efficacy of ethanolic extracts of
Chromolaena odorata and Androgaphis paniculata leaves. The two
plants were evaluated for their anti-malaria efficacy in vivo in a 4-day
curative test assay against Plasmodium berghei strain in mice. The
group treated with 500mg/ml dose of ethanolic extract of A.
paniculata plant showed parasite suppression with increase in Packed
Cell Volume (PCV) value except day 3 which showed a slight
decrease in PCV value. During the 4-day curative test, an increase in
the PCV values, weight measurement and zero count of Plasmodium
berghei parasite values was recorded after day 3 of drug
administration. These results obtained in group treated with A.
paniculata extract showed anti-malarial efficacy with higher
mortality rate in parasitaemia count when compared with
Chromolaena odorata group. These results justify the use of
ethanolic extracts of A. paniculata plant as medicinal herb used in
folklore medicine in the treatment of malaria.





References:
[1] Aiyeloja, A. A. and Bello, O. A. (2006). Ethnobotanical potentials of
common herbs in Nigeria: A case study of Enugu state. Educ. Res. Rev.
1(1):16-22.
[2] Anopheles.Availableonline:http://en.wikipedia.org/wiki/Anopheles
(accessed on 10 May 2012).
[3] Bako SP, Bakfur MJ, John I, Bala EI (2005). Ethnomedicinal and
phytochemical profile of some savanna plant species in Nigeria. Int. J.
Bot. 1(2):147-150.
[4] Bronner, U.; Divis, P.C.; Farnert, A.; Singh, B. Swedish Traveller with
Plasmodium Knowlesi Malaria After Visiting Malaysian Borneo. Malar.
J. 2009, 8, 15.
[5] Chandel, S. Bagai, U. (2010). Anti-plasmodial activity of
Ajugabracteosa against P. bergei infected BALB/C mice. Indian J. Med
Res.131: 440-444.
[6] Christensen SB, KharazmiA (2001). Antimalarial natural products.
Isolation, characterisation and biological properties. In. Bioactive
compounds from natural sources: Isolation, characterisation and
biological properties. Tringali C. Ed. Taylor & Francis: London, pp.
379-432.
[7] David AF, Philip JR, Simon IC, Reto B, Solomon N (2004).
Antimalarial drug discovery: Efficacy models for compound screening.
Nassture Rev., 3: 509-520.
[8] Gessler MC, Nkunya MHH, Mwasumbi LB, Heinrich M, Tanner M
(1994). Screening Tanzanian medicinal plants for antimalaria activity.
Acta Trop. 56:65-77.
[9] Hopkins, H.; Talisuna, A.; Whitney, CJM, Marsh, K. (2007). Impact of
home based management of malaria on health outcomes in Africa: A
systemic Review of evidence. Malaria Journal 6:134-139.
[10] Murray, C.J.L.; Rosenfeld, L.C.; Lim, S.S.; Andrews, K.G.; Foreman,
K.J.; Haring, D.; Fullman, N.;Mohsen, N.; Rafael, L.; Lopez, A.D.
Global malaria mortality between 1980 and 2010: A systematic analysis.
Lancet 2012, 379, 413–431.
[11] Oaks, S.C.; Mitchell, V.S.; Pearson, G.W. Malaria: Obstacles and
Opportunities; Carpenter, C.C.J., Ed.; National Academy: Washington,
WA, USA, 1991.
[12] Odugbemi TO, Akinsulire OR, Aibinu IE, Fabeku PO (2007). Medicinal
plants useful for malarial therapy in Okeigbo, Ondo State, Southwest
Nigeria. Afr. J. Trad. CAM 4(2):191-198.
[13] Pedroni HC, Betton CC, Spalding SM, Coaster TD (2006). Plasmodium:
Development of an irreversible experimental malaria model in Wister
rats. Exp. Parasitol., 113: 193-196.
[14] Peters W (1965). Drug resistance in Plasmodium berghei. Vinka and
Lips. Exp. Parasitol., 17: 80-89.
[15] Phlipson JD and Wright CW (1990). Antiprotozoal compound from
plants sources. Planta Medica. 98(7): 733-739.
[16] Prudencio M, Rodriguez A, Mota MM (2006). The silent path to
thousands of merozoites: the plasmodium liver stage. Nat. Rev.
Microbiol. 4:84-856.
[17] Sachs, J.; Malaney, P. The economic and social burden of malaria.
Nature 2002, 415, 680–685.
[18] Thomas AM, Van Der Wel AM, Thomas AW, Janse CJ, Waters AP
(1998). Transfection systems for animal models of malaria. Parasitol.
Today, 14: 248-249.
[19] World Health Organization (1998) Malaria: Know the facts. World
Health Organization Newsletter 13(1): 6-7
[20] World Health Organization Regional Office for South-East Asia.
Anopheline Species Complexes in South and South-East; World Health
Organization Regional Office for South-East Asia: New Delhi, India,
2007; pp. 102.